Navigation Links
Bruin Biometrics, LLC Conducts Clinical Trials to Detect Pressure Ulcers with the SEM Scanner
Date:11/21/2013

LOS ANGELES, Nov. 21, 2013 /PRNewswire/ -- Bruin Biometrics, LLC ("BBI") today announced results from two IRB-approved clinical trials conducted with the SEM Scanner, a Class IIA medical device that is intended to detect localized tissue edema and pressure induced tissue damage which may lead to the formation of pressure ulcers.

BBI enrolled thirty-one healthy subjects in a pilot study conducted in Los Angeles, California to assess the reliability of the SEM Scanner. Results indicate that the SEM Scanner gives consistent readings and is reliable across different users and across different device models.

BBI also sponsored an investigational, non-significant risk study to collect data needed to analyze SEM Scanner readings at the University of Massachusetts Memorial Medical Center in Worcester, Massachusetts. Fifty subjects from the adult Critical Care Unit were enrolled in the trial and followed for five days. Although the medical center reports annual pressure ulcer incidence of 5.08%, zero subjects developed a pressure ulcer during the course of the BBI trial. Analysis of trial data is underway, and a final study report is expected in early 2014.

BBI will sponsor additional trials throughout 2014. The first will take place in the United States and will evaluate SEM Scanner readings in subjects with known pressure ulcers. A second study will enroll subjects throughout the United States and Europe in order to evaluate the SEM Scanner's effectiveness in lowering the incidence of pressure ulcers against the current standard of care.

About the SEM Scanner:

The SEM Scanner is a point of care diagnostic device that measures increased fluid content within the underlying tissue of skin known as subepidermal moisture (SEM). In clinical studies, SEM has been shown to identify pressure-induced tissue damage — including pressure ulcers — up to 10 days before damage is visible on the skin's surface. BBI developed the SEM Scanner in conjunction with research colleagues at the University of California at Los Angeles (UCLA), notably Barbara Bates-Jensen, PhD, RN, CWOCN, FAAN.

The SEM Scanner is not yet available for sale in the United States. For additional information, please visit www.bruinbiometrics.com.


'/>"/>
SOURCE Bruin Biometrics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Bruin Biometrics, LLC Announces New Board Members
2. Columbia Asia Referral Hospital, Yeshwanthpur, Successfully Conducts HOLEP to Treat a 72-Year-old With Urology Disorder
3. Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
4. PRA Named "Clinical Company of the Year" in National Contest for Second Year
5. Teledyne DALSA Expands Dynamic Flat Detector Series to Benefit Clinical Procedures
6. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
7. Non-Randomized, Multi-Center US Clinical Trial of the GORE ACUSEAL Vascular Graft Presented at VEITHsymposium in New York
8. Daiichi Sankyos Once-Daily Edoxaban Meets Primary Efficacy Endpoint for Stroke Prevention and Superiority for the Principal Safety Endpoint Compared to Warfarin for Patients with Atrial Fibrillation in a Phase 3 Clinical Trial
9. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
10. Xcelience hires Clinical Supplies VP; Opens Birmingham, UK Site
11. Omeros Reports Phase 3 OMS302 Clinical Data Presented at the Annual American Academy of Ophthalmology Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Global Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, ... 2024" report to their offering. ... The global pharmacogenomics market was valued at US$ ... 11,938.8 Mn by 2024, expanding at a CAGR of 5.6% ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical Center ... in Nashville , Tennesse have been ... Sphincter Stimulation for GERD (LESS GERD) trial. The EndoStim ... long-term reflux control by restoring normal function to the ... million people in the United States ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s ... dental services to 1,961 people during the April 22-23 event at the San Mateo ... Californians who experience barriers to care, CDA Cares educates the public and policymakers about ...
(Date:4/24/2017)... Illinois (PRWEB) , ... April 24, 2017 , ... Veteran ... What happened next changed her life forever. , In “Healing Tears,” James depicts every ... the advice of my attorney, I began journaling conversations and situations throughout my divorce,” ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP ... food supplements, announced its popular products are now available for purchase on StackedNutrition.com, ... prioritizes the use of premium natural ingredients in making all of its products. ...
(Date:4/24/2017)... ... April 24, 2017 , ... My T Chai, a South African ... now available for purchase on RevNutrition.com, a popular website specializing in sales of nutritional ... popularized in ancient India and Siam. It spread across Asia and Africa quickly, and ...
(Date:4/24/2017)... ... April 24, 2017 , ... symplrTM, ... credentialing solutions, today announced that Kyle Allain has joined the company as Vice ... sales and operations, including provider, payor and managed care solutions. , A ...
Breaking Medicine News(10 mins):